CVS Health Corporation (NEO: CVS)
Canada flag Canada · Delayed Price · Currency is CAD
11.05
+0.15 (1.38%)
Dec 20, 2024, 4:00 PM EST

CVS Health Statistics

Total Valuation

CVS Health has a market cap or net worth of CAD 80.23 billion. The enterprise value is 185.42 billion.

Market Cap 80.23B
Enterprise Value 185.42B

Important Dates

The next estimated earnings date is Wednesday, February 12, 2025.

Earnings Date Feb 12, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -2.08%
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 1.26B

Valuation Ratios

The trailing PE ratio is 11.84.

PE Ratio 11.84
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.49, with an EV/FCF ratio of 81.36.

EV / Earnings 27.36
EV / Sales 0.35
EV / EBITDA 7.49
EV / EBIT 13.54
EV / FCF 81.36

Financial Position

The company has a current ratio of 0.80, with a Debt / Equity ratio of 1.10.

Current Ratio 0.80
Quick Ratio 0.54
Debt / Equity 1.10
Debt / EBITDA 4.80
Debt / FCF 49.02
Interest Coverage 3.30

Financial Efficiency

Return on equity (ROE) is 6.70% and return on invested capital (ROIC) is 3.81%.

Return on Equity (ROE) 6.70%
Return on Assets (ROA) 2.37%
Return on Capital (ROIC) 3.81%
Revenue Per Employee 1.91M
Profits Per Employee 26,113
Employee Count 300,000
Asset Turnover 1.46
Inventory Turnover 17.78

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -42.63% in the last 52 weeks. The beta is 0.53, so CVS Health's price volatility has been lower than the market average.

Beta (5Y) 0.53
52-Week Price Change -42.63%
50-Day Moving Average 13.97
200-Day Moving Average 15.23
Relative Strength Index (RSI) 26.36
Average Volume (20 Days) 25,059

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 1.29

Income Statement

In the last 12 months, CVS Health had revenue of CAD 496.13 billion and earned 6.78 billion in profits. Earnings per share was 5.34.

Revenue 496.13B
Gross Profit 68.51B
Operating Income 12.88B
Pretax Income 9.09B
Net Income 6.78B
EBITDA 19.07B
EBIT 12.88B
Earnings Per Share (EPS) 5.34
Full Income Statement

Balance Sheet

The company has 13.08 billion in cash and 111.73 billion in debt, giving a net cash position of -98.65 billion.

Cash & Cash Equivalents 13.08B
Total Debt 111.73B
Net Cash -98.65B
Net Cash Per Share n/a
Equity (Book Value) 101.46B
Book Value Per Share 80.48
Working Capital -23.35B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.23 billion and capital expenditures -3.95 billion, giving a free cash flow of 2.28 billion.

Operating Cash Flow 6.23B
Capital Expenditures -3.95B
Free Cash Flow 2.28B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 13.81%, with operating and profit margins of 2.60% and 1.37%.

Gross Margin 13.81%
Operating Margin 2.60%
Pretax Margin 1.83%
Profit Margin 1.37%
EBITDA Margin 3.84%
EBIT Margin 2.60%
FCF Margin 0.46%

Dividends & Yields

CVS Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 66.07%
Buyback Yield 2.08%
Shareholder Yield 2.08%
Earnings Yield n/a
FCF Yield n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CVS Health has an Altman Z-Score of 2.13. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.13
Piotroski F-Score n/a